Jumonji domain-containing protein RIOX2 is overexpressed and associated with worse survival outcomes in prostate cancers

Jumonji domain-containing protein RIOX2 is overexpressed and associated with worse survival outcomes in prostate cancers

BackgroundHistone demethylase RIOX2 was cloned as a c-Myc downstream gene involved in cell proliferation and has been implicated as an oncogenic factor in multiple tumor types. Its expression profiles and correlation with disease progression in prostate cancers are unknown.MethodsTranscriptomic prof...

Full description

Bibliographic Details
Main Authors: Chenchen He, Wang Liu, Jiahao Sun, Da Zhang, Benyi Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Oncology
Subjects:
RIOX2
prostate cancer
patient survival
disease progression
Myc protein
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1087082/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1087082/full

Similar Items